Clinical trials
2 active studies led by GentiBio, Inc, of 2 in all
Source: ClinicalTrials.gov, Studies with GentiBio, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show GentiBio, Inc in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by GentiBio, Inc or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by GentiBio, Inc, of 2 in all
Source: ClinicalTrials.gov, Studies with GentiBio, Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show GentiBio, Inc: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets GentiBio, Inc is in.
Stories on the topics GentiBio, Inc works in.
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read
Atrial fibrillation raises stroke risk about five-fold. Holter monitors, patches, implants and smartwatches…
Read
Over 9.5 million people live with type 1 diabetes and need insulin every day. How delivery devices are…
Read